Three buys for post-COVID gains: DuPont, Dow Inc. and Corteva

Article Excerpt

The breakup of multinational chemical maker DowDuPont into three separate firms—Dupont de Nemours, Dow, and Corteva—is a great example of how spinoffs can unlock hidden value for investors. Looking at the two new firms, Dow has gained roughly 30% while Corteva has jumped 60%. The share price of the former parent, DuPont de Nemours, has stayed flat due to the impact of COVID-19 on global manufacturing activity. However, the continuing rollout of vaccines will let most businesses re-open and should spur DuPont’s earnings and its share price this year. We also like the long-term prospects of both Dow and Corteva. DUPONT DE NEMOURS, INC. $77 is a buy. The company (New York symbol DD; Manufacturing & Industry sector; Shares outstanding: 534.2 million; Market cap: $41.1 billion; Dividend yield: 1.6%; Takeover Target Rating: Medium; www.dupont.com) makes chemicals and other products through three main divisions: Electronics & Industrial; Mobility & Materials; and Water & Protection. Since June 2019, it has divested (or agreed to sell) nine businesses for total cash…